Study shows impact of weight loss drugs on nerve cells in brain
Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body weight. The drug is already well established as part of the treatment for obesity and type 2 diabetes but can cause side effects such as nausea and muscle loss.
In the study, researchers at the Sahlgrenska Academy at the University of Gothenburg showed that it is possible to distinguish the nerve cells in the brain that control the beneficial effects --such as reduced food intake and fat loss -- from those that contribute to side effects.
To investigate how semaglutide affects the brain, the researchers worked with mice. They tracked which nerve cells were activated by the drug and were then able to stimulate these cells—without administering the drug itself.
The results, published in the journal Cell Metabolism, revealed that the mice ate less and lost weight, just as they did when treated with semaglutide.
When these nerve cells were killed, the drug's effect on appetite and fat loss instead decreased significantly. However, side effects such as nausea and muscle loss remained.
"This suggests that these nerve cells control the beneficial effects of semaglutide. We have therefore identified a specific group of nerve cells that is necessary for the effects that semaglutide has on weight and appetite, but which does not appear to contribute to any significant extent to side effects such as nausea.
"If we can target the treatment there, we may be able to maintain the positive effects while reducing side effects," says Júlia Teixidor-Deulofeu, first author of the study and Ph.D. student at Sahlgrenska Academy at the University of Gothenburg.
The identified nerve cells are located in an area of the brain called the dorsal vagal complex.
The team noted that the finding is not only an early step toward potentially improved treatment, but it also provides new knowledge about how semaglutide works in the brain.
The study also provides deeper insight into how the brain stem regulates our energy balance.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
3 days ago
- Time of India
Changes in DNA can help determine heart risks of type 2 diabetes patients
London: New findings from a Swedish study of people with recently diagnosed type 2 diabetes could help doctors identify those at low risk for developing cardiovascular diseases versus those at higher risk. Overall, people with type 2 diabetes are up to four times more likely to experience a heart attack , stroke, or another major cardiovascular event, compared to people without diabetes. The 752 volunteers in the new study all had new diagnoses of type 2 diabetes, and none had a history of heart disease. During roughly seven years of follow-up, 102 of them suffered serious cardiovascular complications. By analyzing blood samples obtained from participants at regular intervals, the researchers were able to track chemical changes in DNA over time. Such changes, called DNA methylation , "control which genes are active or turned off in our cells, and when it does not work properly, it can contribute to the development of cardiovascular disease," study leader Charlotte Ling of Lund University said in a statement. The researchers found more than 400 sites with altered DNA methylation in blood. They were able to use 87 sites to develop a score scale that can assess patients' risk of developing serious cardiovascular complications. The scale's negative predictive value - its accuracy at identifying patients at low risk of a major cardiovascular event - was 96%, researchers reported in Cell Reports Medicine. But the scale was only about 32% accurate at identifying patients at high risk - possibly because the study has not yet followed them for a long enough period. Still, the researchers wrote, their screening test "seems to be one of the most reliable prognostic tools" for discriminating patients with type 2 diabetes at low cardiac risk from those at possibly high risk, "allowing personalized treatment, optimized healthcare costs, and reduction of therapy-related side effects and patients' worries." Healthcare providers currently look at clinical variables such as age, gender, blood pressure, smoking, harmful cholesterol, long-term blood sugar and kidney function to estimate the risk of future heart disease, "but it is a rather blunt tool," Ling said. "If you add DNA methylation, you have a much better measure of a future risk." COMPOUND IN MAPLE SYRUP FIGHTS TOOTH DECAY A natural compound in the syrup from maple tree sap can help fight tooth decay, according to new findings that might lead to oral care products with no alcohol and fewer chemicals, researchers said. The compound known as epicatechin gallate , or ECG, prevents cavity-causing bacteria from growing on teeth and "is a powerful and safe alternative to traditional plaque-fighting agents," the researchers said in a statement. "Its natural abundance, affordability and lack of toxicity make it especially promising for inclusion in oral care products such as mouthwashes, offering a safer option for young children, who often accidentally swallow mouthwash," they added. The idea for their study grew from their discovery in an unrelated experiment that Listeria bacteria - a common cause of food poisoning - can grow and form biofilms on most plants and wood but not on maple. Working with maple sap and diluted maple syrup, the researchers isolated the compound that inhibits Listeria attachment and experimented to see whether it would have similar effects on Streptococcus mutans , the bacteria that cause biofilms on teeth, also known as plaque, and dental cavities. The researchers first tested their theory in computer models, according to a report in Microbiology Spectrum. Next, they confirmed that ECG inhibits the cavity-causing bacteria in test tube experiments. Finally, they determined that it blocks S. mutans from forming biofilms on plastic teeth and on disks made from hydroxyapatite, the substance in real tooth enamel. ECG is also present in green and black tea, in much higher amounts than in maple sap or syrup. Drinking green tea has long been associated with lower rates of cavities, the authors said. "Our findings suggest that ECG or (similar compounds with similar effects) could be added to dental products to help prevent cavities through an antibiofilm mechanism," study leader Mark Gomelsky of the University of Wyoming said in a statement. "This is different from traditional approaches, which rely on killing bacteria with alcohol, disinfectants or essential oils, or on fluoride to remineralize enamel."
Indian Express
3 days ago
- Indian Express
COMBAT dengue: India-EU science alliance takes aim at dengue in global health push
Dengue fever affects nearly 400 million people annually, with India among the countries most severely impacted. Now, as part of the India-EU partnership under the Horizon Europe program, the COMBAT dengue initiative will soon be launched to tackle the world's most rapidly spreading viral infection. This project brings together top researchers, clinicians, and technologists across both continents. The Swedish Karolinska Institute in Stockholm coordinates the COMBAT research initiative. The acronym stands for 'Advancing Pandemic Preparedness Innovative Multidisciplinary Strategies for COMBATing Severe Dengue'. Dr Ujjwal Neogi, Project Coordinator, Karolinska Institute, told The Indian Express, 'Infectious diseases don't respect borders. The aim is to uncover the underlying mechanisms of severe dengue and reduce the disease burden. This can be done through innovation, precision medicine, and translational research, which will contribute to saving lives, protecting the brain, and strengthening preparedness for future outbreaks.' 'It is not just a response to dengue, but also a critical advancement in global health, integrating fundamental science with clinical and societal applications,' Dr Neogi further said. Scientists involved in the project said that while dengue fever has primarily occurred in tropical and subtropical regions, the risk of contracting the disease is also rising in Europe due to climate change. At present, India bears a significant share of the dengue burden, and as per data from the National Centre for Vector Borne Diseases Control, close to 12 lakh lab-confirmed dengue cases and over 1,650 deaths have been reported since 2019 till March this year. However, experts like Dr Swarup Sarkar of the World Health Organization, who is advising the COMBAT project, said that the dengue problem is compounded by underreporting in India and other South Asian countries. 'Pending vaccine trial results and good clinical protocols, there is a need for biomarkers to identify potential severe cases that would be helpful to reduce adverse outcomes due to dengue,' Dr Sarkar said. Led by Prof Arindam Maitra, National Institute of Biomedical Genomics, Kalyani, West Bengal, clinical samples will be collected from Artemis Hospital and Max Hospital in New Delhi, and Kasturba Medical College Hospital in Mangaluru. Scientists said that these sites, located in regions with high dengue prevalence, are central to generating critical scientific insights that will not only strengthen India's outbreak response capabilities but also contribute to global knowledge alongside cohorts in Guatemala. They also said that the data and findings will support the European Union's efforts to enhance pandemic preparedness against emerging and re-emerging infectious diseases. Scientists said what sets COMBAT apart is its integration of high-end, innovative, and affordable technologies seldom seen in virus research. The project employs brain organoids, miniature, lab-grown human brain-like tissues, to investigate how dengue invades the nervous system. Advanced super-resolution and photonic microscopy allow scientists to visualise the virus in action within living cells, while artificial intelligence sifts through complex patient data to discover biomarkers that could predict severe disease outcomes. The approach is a fusion of virology, physics, engineering, and data science, emblematic of the EU-India strategy to position science at the crossroads of innovation and accessibility, according to scientists. They also noted that COMBAT dengue also comes at a vital moment in India-EU relations, following the renewal of the Science and Technology Cooperation Agreement until 2030. Though dengue is the immediate target, the platform being developed has wider ambitions. The technologies and workflows created under COMBAT – from multi-modal imaging to AI-integrated biological pipelines – are designed to be rapidly adaptable to other pathogens. Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition. ... Read More
Time of India
31-07-2025
- Time of India
Older adults who follow healthy diets accumulate chronic diseases more slowly
Stockholm/Barcelona: Imagine two people in their 70s. Both are active, live independently and enjoy life. But over the next 15 years, one of them develops two or three chronic illnesses - heart disease, diabetes, depression - while the other remains relatively healthy. What made the difference? According to our new research, diet may be a key part of the answer. In our new study, our group at the Aging Research Center at the Karolinska Institutet, Sweden, followed more than 2,400 older Swedish adults for 15 years. We found that people who consistently ate a healthy diet developed chronic diseases more slowly, in contrast to those whose diets were considered more inflammatory; that is, diets high in processed meats, refined grains and sugary drinks, which are known to promote low-grade chronic inflammation in the body. This is important because having several health conditions at the same time is one of the biggest problems older people face. It increases the risk of disability, hospitalisation and early death. It also places a huge burden on healthcare systems. But while it has been long known that diet can help prevent individual diseases, our study shows that it may also influence the overall pace of biological ageing. We looked at four well-known dietary patterns. Three of them - the Mind diet (designed to protect brain health), the Alternative Healthy Eating Index (based on foods linked to lower disease risk) and the Mediterranean diet - were associated with slower disease accumulation. The fourth, a diet high in inflammatory foods, was linked to faster accumulation. The strongest associations were seen for cardiovascular and psychiatric conditions. So, people who ate better were less likely to develop diseases including heart failure, stroke, depression or dementia. We did not, however, find a clear link between diet and musculoskeletal diseases such as arthritis or osteoporosis. Some of the benefits of healthy eating were more pronounced in women and in the oldest participants: those aged 78 and above. This suggests that it is never too late to make changes. Even in very old age, diet matters. Why does food have such a strong potential? One reason may be inflammation. As people age, many develop low-grade chronic inflammation - sometimes called " inflammaging " - which is linked to a wide range of diseases. Diets high in vegetables, fruits, whole grains, and healthy fats tend to reduce inflammation. Diets rich in highly processed foods and sugar do the opposite. Another reason is that healthy diets support the body's resilience. They provide essential nutrients that help maintain immune function, muscle mass and cognitive health. Over time, this can make a big difference in how people age. Our study is one of the longest and most comprehensive of its kind. We used repeated dietary assessments and tracked more than 60 chronic health conditions. We also tested our findings using different analytical methods to make sure they held up. Of course, diet is just one piece of the puzzle. Physical activity, social connections and access to healthcare all play important roles in healthy ageing. But improving diet quality is a relatively simple and accessible way to help older adults live longer, healthier lives. So what should older adults eat? The message is clear: eat plenty of vegetables, fruits, legumes, nuts and whole grains. Choose healthy fats like rapeseed oil and fish. Limit red and processed meats, sugary drinks and solid fats. These are the building blocks of the diets we studied - and they have been associated with slower ageing, better brain health and fewer chronic diseases in this and other research. Ageing is inevitable. But people can shape how it unfolds. Our findings suggest that even small changes in diet can make a meaningful difference in how people experience later life, regardless of their age. (The Conversation)
